尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Lovell Stephanie. Insider active across 1 company, notably TransMedics Group, Inc.. Aggregated, 5 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €154k. History available since 22 November 2022. The latest transaction was filed on 4 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Lovell Stephanie is a declarant and, according to the provided records, she is a Director of TransMedics Group, Inc. (XNAS). She has 5 filings in total, and across the sampled recent filings the reported sell amount is EUR 153714, with filings dated from 2022-11-23 to 2026-03-06. The modal transaction nature reported is Attribution.